Big pharma, Biotech, Partnering, Pharma

Aduro signs a pharma deal worth $847 million with Janssen

Posted on 17 October 2014

Tags: , , ,

Aduro Biotech just inked a pharma deal with the Johnson & Johnson Innovation Center in California to help it develop its nascent lung cancer therapies.

Janssen Biotech, part of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), will receive an exclusive, worldwide license to several of the cancer drugs in Aduro’s LADD immunotherapy platform

Aduro will receive a $30 million up front and as much as $817 million as it hits development, regulatory and commercialization milestones payments.

The company’s primary focus is experimental therapies using Listeria bacteria, which they genetically modify with disease-specific antigens. It had an earlier, existing partnership with Johnson & Johnson, but the larger company appears to be doubling down on the company as research evolves.

Aduro lauded the agreement as a major step forward for the tiny biotech.

For further deal information visit Current Agreements (subscription required)


Report: Partnering Deals and Alliances with Johnson & Johnson

Report:   Top 50 Big Pharma Partnering and M&A Deal Trends

Report:   Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply